Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference
2023年5月12日 - 9:00PM
Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”)
(Nasdaq: ADPT), a commercial stage biotechnology company that aims
to translate the genetics of the adaptive immune system into
clinical products to diagnose and treat disease, today announced it
will be participating in the upcoming 2023 RBC Capital Markets
Global Healthcare Conference in New York, New York.
Adaptive Biotechnologies’ management is
scheduled to participate in a fireside chat on Tuesday, May 16th at
3:35 p.m. Eastern Time. Interested parties may access a live and
archived webcast of the presentation on the “Investors” section of
the company website at: www.adaptivebiotech.com.
About Adaptive BiotechnologiesAdaptive
Biotechnologies (“we” or “our”) is a commercial-stage biotechnology
company focused on harnessing the inherent biology of the adaptive
immune system to transform the diagnosis and treatment of disease.
We believe the adaptive immune system is nature’s most finely tuned
diagnostic and therapeutic for most diseases, but the inability to
decode it has prevented the medical community from fully leveraging
its capabilities. Our proprietary immune medicine platform reveals
and translates the massive genetics of the adaptive immune system
with scale, precision and speed. We apply our platform to partner
with biopharmaceutical companies, inform drug development, and
develop clinical diagnostics across our two business areas: Minimal
Residual Disease (MRD) and Immune Medicine. Our commercial products
and clinical pipeline enable the diagnosis, monitoring, and
treatment of diseases such as cancer, autoimmune disorders, and
infectious diseases. Our goal is to develop and commercialize
immune-driven clinical products tailored to each individual
patient.
ADAPTIVE MEDIAErica Jones, Associate Corporate
Communications Director206-279-2423media@adaptivebiotech.com
ADAPTIVE INVESTORSKarina Calzadilla, Vice
President, Investor
Relations201-396-1687investors@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
過去 株価チャート
から 4 2024 まで 5 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
過去 株価チャート
から 5 2023 まで 5 2024